These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1017154)

  • 21. Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis.
    Maggiore Q; Biagini M; Zoccali C; Misefari M
    Proc Eur Dial Transplant Assoc; 1975; 11():222-8. PubMed ID: 1197257
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
    Pigliucci GM; Suraci V; Alcini E
    Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-beta adrenoreceptor blockade activity of plasma ultrafiltrate in two uraemic patients: effect of parathyroidectomy.
    Lhoste F; Drüeke T; Larno S; Man NK; Zingraff J; Jlngers P; Boissier JR
    Biomedicine; 1976 Jul; 25(5):181-4. PubMed ID: 187262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propranolol-associated hypoglycemia in patients on maintenance hemodialysis.
    Zarate A; Gelfand M; Novello A; Knepshield J; Preuss HG
    Int J Artif Organs; 1981 May; 4(3):130-4. PubMed ID: 7275342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Deliberate self-overdose with propranolol. Changes in serum levels (author's transl)].
    Ducret F; Zech P; Perrot D; Moskovtchenko JF; Traeger J
    Nouv Presse Med; 1978 Jan; 7(1):27-8. PubMed ID: 662597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies of hypertension in chronic glomerulonephritis. 2. Hypertension in the uremic phase: relationship between hemodynamic changes and plasma renin activity during hemodialysis].
    Nishio I
    Nihon Jinzo Gakkai Shi; 1974 Jan; 16(1):20-32. PubMed ID: 4471777
    [No Abstract]   [Full Text] [Related]  

  • 29. High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.
    Zito RA; Cassell I; Cunningham M; Gradman AH; Ross AM; Zaret BL
    Yale J Biol Med; 1980; 53(3):173-9. PubMed ID: 6250292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent disposition of oral propranolol in normal subjects.
    Mackichan JJ; Pyszczynski DR; Jusko WJ
    Biopharm Drug Dispos; 1980; 1(4):159-66. PubMed ID: 7448344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive propranolol metabolite retention during maintenance hemodialysis.
    Stone WJ; Walle T
    Clin Pharmacol Ther; 1980 Oct; 28(4):449-55. PubMed ID: 7408404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spurious hyperbilirubinemia in uremic patients on propranolol therapy.
    Stone WJ; McKinney TD; Warnock LG
    Clin Chem; 1979 Oct; 25(10):1761-5. PubMed ID: 476926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effect of propranolol on the steady-state plasma levels of ketanserin.
    Trenk D; Lühr A; Radkow N; Jähnchen E
    Arzneimittelforschung; 1985; 35(8):1286-8. PubMed ID: 2934070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
    Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
    Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.